Pavel Hamet

Last updated

Pavel Hamet is a doctor, researcher, editor, academic administrator and teacher in Quebec, Canada.

Contents

Working in the medical field, he is the Canada Research Chair in Predictive Genomics of hypertension and cardiovascular diseases. He is Professor of Medicine at the University of Montreal, Adjunct Professor of Experimental Medicine at McGill University, and visiting professor at the First Faculty of Medicine at Charles University, Prague, Czech Republic. He is currently Chief of Gene Medicine and member of the Endocrinology Services at the University of Montreal's Research Centre (CRCHUM). [1] He was designated president of the International Society of Pathophysiology (ISP) from 2010 to 2014. Associated editor of the Journal of Hypertension , [2] he is also a member of the Commission de l'éthique en science et en technologie of the Quebec government and president, chief of the scientific direction of Medpharmgene. [3] compagny.

Biography

Born in Czech Republic (or Protectorate of Bohemia and Moravia?), Pavel Hamet received his Doctorate in medicine in 1967 from Charles University, a Ph.D. in Experimental Medicine from McGill University in 1972, and a CSPQ in Endocrinology from Université de Montréal in 1974. He then completed two years of postdoctoral training at Vanderbilt University in the US after which he started his career as a microbiologist. In 1966, he had the opportunity to visit Montreal during a contest organized by the International Federation of Medical Students' Association (IFMSA). [4] In 1967, he finished a PhD in medicine at Charles University, the same year he established in Quebec.

Once in Montreal, he met with Jacques Genest who offered him a scholarship at the Institut de recherches cliniques de Montréal (IRCM) affiliated with the University of Montreal. He then founded and directed the University of Montreal's Research Centre (CRCHUM) from 1996 to 2006. [5] From 2014, Hamet led a public-private $18.4 million project for Optimization of personalized therapeutic approaches in primary care entitled Optithera. [6]

Contributions

Hamet is the author or co-author of over 575 scientific publications and holds several international patents. He serves on many national and international committees including the Canadian Institute of Circulatory and Respiratory Health (ICRH). His major scientific contributions [7] are in the areas of hypertension, diabetes and cardiovascular diseases, using approaches that range from bench to the bedside of the patient. Hamet contributed to the establishment of the role of the second messenger cGMP in signal transduction of hormones (this enzyme became later the target of Viagra); he improved the treatment of hypertension (HTN) in Canada, contributed to the research on diabetes, a field in which he is still working on identifying the genetic determinants responsible for complications and establishing the foundations of personalized medicine in Québec.[ citation needed ]

Recognition

Hamet has received many honors, including the Harry Goldblatt Award from the American Heart Association in 1990 for his achievements in the field of hypertension. In 2008, Hamet had the honor to be named as an Officer of the Ordre National du Québec and he received the prestigious Okamoto Award from the Japan Vascular Disease Research Foundation. [8]

In 2012, the Société Francophone du Diabète (France) honoured him with the Roger Assan Award and in 2013 he received from the Centre de Recherche du CHUM "le Prix Excellence" to underline his remarkable career.[ citation needed ]

Awards

Related Research Articles

Jacques Genest was a Canadian physician and scientist. He founded the Institut de recherches cliniques de Montréal (IRCM) and was an emeritus professor at Université de Montréal and a professor at McGill University. Genest was best known for founding and leading several organizations related to clinical research in Québec and for his work on arterial hypertension.

<span class="mw-page-title-main">Prix Wilder-Penfield</span>

The Prix Wilder-Penfield is an award by the government of Quebec that is part of the Prix du Québec, which "goes to scientists whose research aims fall within the field of biomedicine. These fields include the medical sciences, the natural sciences, and engineering". It is named in honour of Wilder Penfield.

Jean Davignon, is a Canadian physician, medical researcher, and academic.

The Léo-Pariseau Prize is a Québécois prize which is awarded annually to a distinguished individual working in the field of biological or health sciences. The prize is awarded by the Association francophone pour le savoir (Acfas), and is named after Léo Pariseau, the first president of Acfas.

The Marcel-Piché Prize is awarded to a researcher at the Institut de recherches cliniques de Montréal (IRCM) "in recognition of the quality of [biomedical] research and in recognition of the contribution to the growth and outreach of the Institute." The prize is named after Marcel Piché, a Montreal lawyer involved with the IRCM.

The Prix Michel-Sarrazin is awarded annually in the Canadian province of Quebec by the Club de Recherches Clinique du Québec to a celebrated Québécois scientist who, by their dynamism and productivity, have contributed in an important way to the advancement of research biomedical. It is named in honour of Michel Sarrazin (1659–1734) who was the first Canadian scientist.

<span class="mw-page-title-main">Raphaël Lépine</span> French physiologist

Jacques Raphaël Lépine was a French physiologist who was a native of Lyon.

Luc Vinet is a Canadian physicist and mathematician. He was former rector of the Université de Montréal between 2005 and 2010. He is the CEO of IVADO, created in 2015 since August 2021.

Expenditures by Canadian universities on scientific research and development accounted for about 40% of all spending on scientific research and development in Canada in 2006.

Michel Chrétien is a Canadian medical researcher specializing in neuroendocrinology research at the Institut de recherches cliniques de Montréal, or Clinical Research Institute of Montreal, (IRCM). He is a younger brother of former Canadian prime minister, Jean Chrétien.

<span class="mw-page-title-main">André Lussier</span> Canadian rheumatologist (1933–2009)

André Lussier (1933–2009) was a physician, rheumatologist, and professor at the School of Medicine of the Université de Sherbrooke, Quebec, Canada. He was born and died in Sherbrooke. He completed his classical studies and Baccalauréat ès-art at the Séminaire Oblat de Chambly and at the Collège de Montréal. He then completed his residency in internal medicine at the Hôpital Notre-Dame de Montréal. From 1963 to 1964, he pursued a "clinical and research fellowship" in rheumatology at the University of Pennsylvania under the supervision of Dr. Joseph Hollander. In 1969, he joined the founding clinicians and researchers of the School of Medicine of the Université de Sherbrooke and he established the first Section of Rheumatology officially recognized in Québec. In 1970, he wrote the white paper upon which the specialty of rheumatology is recognized in Québec, two years before its recognition as a specialty elsewhere in North America. In 1975, he co-founded The Journal of Rheumatology, of which he remained the co-Editor until his death. He was the first Director of the Clinical Research Center. of the Centre Hospitalier Universitaire de Sherbrooke (CHUS) from 1980 to 1984. During his career, he was president of several scientific meetings and conferences. He has published over 230 scientific articles and is the author of three books.

Gérard Bélanger is a Canadian economics professor. He holds a Bachelor of Arts from the Université de Montréal, a Bachelor of Science and a master's degree in Social sciences from the Université Laval, as well as a master's degree from Princeton University. He is a member of the Royal Society of Canada.

Peter Tiffany Macklem, OC, FRCP(C), FRSC was a Canadian doctor, medical researcher and hospital administrator.

<span class="mw-page-title-main">Claude Roy (physician)</span> Canadian doctor in Quebec (born 1928)

Claude C. Roy was a Canadian doctor in Quebec. He is considered one of the founding fathers of the field of paediatric gastroenterology.

Santé Diabète (SD) is a French Non-governmental organization (NGOs) whose headquarters is in Grenoble (France) which is working on strengthening health systems to improve the prevention and management of diabetes in Africa. As part of a chronic disease like diabetes, improving the quality of care saves thousands of lives but also improves the quality of life for people living with diabetes.

Éric A. Cohen is a Canadian molecular virologist whose research is focused on human immunodeficiency virus (HIV)-host interactions that govern viral replication and persistence.

Michel Bouvier is a Canadian biochemist and molecular pharmacologist. He is a professor of biochemistry and molecular medicine at Université de Montréal; a principal investigator and the chief executive officer at the Institute for Research in Immunology and Cancer; and an associate vice-president in Research, Scientific Discovery, Creation, and Innovation at Université de Montréal. His work focuses on the study of cell signaling towards the discovery of new pharmaceutical drugs.

<span class="mw-page-title-main">Institut de recherches cliniques de Montréal</span>

Institut de recherches cliniques de Montréal (IRCM),, is a medical research institute affiliated with Université de Montréal. Its work focuses mainly on cellular biology, molecular biology, genetics, developmental biology, and proteomics. Its aim is to understand the causes of illnesses and develop new therapeutic solutions or cures.

Rhian M. Touyz Koppel MBBCh, MSc (Med), PhD, FRCP, FRSE, FMedSci, FCAHS is a Canadian medical researcher. She is currently serving as the Executive Director and Chief Scientific Officer of the Research Institute of the McGill University Health Centre in Montreal, Canada, since 2021. A clinician scientist, her research primarily focuses on hypertension and cardiovascular disease.

<span class="mw-page-title-main">Eric Racine</span> Bioethicist

Eric Racine FCAHS, is the Director of the Pragmatic Health Ethics Research Unit based at the Montreal Clinical Research Institute, a research professor at the Université de Montréal and the Montreal Clinical Research Institute, and an adjunct professor in the Department of Neurology and Neurosurgery at McGill University.

References

  1. ↑ "Hamet, Pavel" . Retrieved 1 April 2015.
  2. ↑ "Editorial Board : Journal of Hypertension". journals.lww.com. Retrieved 1 April 2015.
  3. ↑ "Management Team - Medpharmgene". www.medpharmgene.ca. Retrieved 1 April 2015.
  4. ↑ "International Federation of Medical Students' Associations (IFMSA) | UNESCO NGO - db". ngo-db.unesco.org. Archived from the original on 2 April 2015. Retrieved 1 April 2015.
  5. ↑ "Pavel Hamet | QNPHC". qnphc.org. Retrieved 1 April 2015.
  6. ↑ "Centre hospitalier de l'Université de Montréal (CHUM) | CHUM Research Centre receives $18.4 million for Opti-Thera project". www.newswire.ca. Retrieved 1 April 2015.
  7. ↑ "Montreal Diabetes Research Center". www.montreal-diabetes-research-center.org. Retrieved 1 April 2015.
  8. ↑ "archive-org.com: fmsq.org - Archives 2008-2009 des prix et distinctions..." archive-org.com. Retrieved 1 April 2015.
  9. ↑ "Les Prix du Québec - le lauréat Pavel Hamet". www.prixduquebec.gouv.qc.ca. Retrieved 1 April 2015.
  10. ↑ "Club des Ambassadeurs - Palais des congrès de Montréal" . Retrieved 1 April 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.